Pet Pharm Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	3,352	3,585	1,656	-	-
Market Cap Growth	-10.11%	116.51%	-	-	-
Enterprise Value	3,240	3,187	1,535	-	-
Last Close Price	57.70	68.62	38.70	-	-
PE Ratio	112.09	143.47	114.14	-	-
PS Ratio	12.62	16.14	12.67	-	-
PB Ratio	2.87	3.00	2.84	-	-
P/TBV Ratio	3.11	3.32	2.89	-	-
P/FCF Ratio	75.80	748.49	-	-	-
P/OCF Ratio	48.45	104.52	57.32	-	-
EV/Sales Ratio	12.20	14.35	11.75	-	-
EV/EBITDA Ratio	48.58	83.45	78.93	-	-
EV/EBIT Ratio	143.22	216.15	189.22	-	-
EV/FCF Ratio	73.27	665.45	-	-	-
Debt / Equity Ratio	0.09	0.09	0.25	0.12	0.32
Debt / EBITDA Ratio	1.61	2.22	5.45	1.99	4.53
Debt / FCF Ratio	2.42	22.17	-	5.97	-
Net Debt / Equity Ratio	-0.10	-0.34	-0.42	-0.29	0.19
Net Debt / EBITDA Ratio	-1.96	-10.81	-12.55	-6.41	4.38
Net Debt / FCF Ratio	-2.53	-86.18	1.53	-14.89	-0.92
Asset Turnover	0.22	0.21	0.21	0.35	-
Inventory Turnover	11.30	7.46	4.96	6.42	-
Quick Ratio	3.40	10.28	3.01	6.18	1.94
Current Ratio	6.03	10.68	3.16	10.97	5.05
Return on Equity (ROE)	2.88%	2.80%	2.91%	3.34%	-
Return on Assets (ROA)	1.16%	0.88%	0.81%	1.40%	-
Return on Capital Employed (ROCE)	1.80%	1.10%	1.30%	1.70%	-2.80%
Earnings Yield	0.90%	0.70%	0.88%	-	-
FCF Yield	1.32%	0.13%	-9.63%	-	-
Dividend Yield	0.42%	0.36%	0.23%	-	-
Payout Ratio	16.83%	20.22%	55.42%	-	-
Buyback Yield / Dilution	-24.82%	-32.26%	-37.19%	-19.84%	-
Total Shareholder Return	-24.39%	-31.90%	-36.96%	-19.84%	-